Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
BioSpace
30m
Neurocrine Gains ‘High-Risk/High-Reward’ Depression Asset From Takeda
Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.
Psychology Today
25m
When Politics and the Mind Collide
Explore how political divisiveness impacts mental health and amplifies high-functioning depression, and discover strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Black boxes recovered
Los Angeles wildfire updates
Cause of death revealed
Apologizes for old tweets
Activists call for boycott
Top leaders asked to resign
Asteroid may hit Earth
Inmate's transfer blocked
Sexual misconduct accusation
Michigan priest loses license
Hamas confirms death
Ex-worker admits to theft
FDA approves painkiller
To raise hourly pay
Recuses self from Act 10 suit
Shiffrin finishes 10th
Searching for joyriders
Granted legal personhood
Nashville bids for franchise
'As Tears Go By' singer dies
2 more victims in indictment
Olympic gold medalist dies
S3 release date revealed
Confirmed interior secretary
Deputy shooting sentence
Blames DEI for crash
DOJ sues to block deal
Ground stop amid IT outage
Related topics
Nasal spray
Food and Drug Administration
Neurocrine Biosciences
Feedback